As global markets navigate through varied economic conditions, including shifts in inflation and trade dynamics, investors are increasingly exploring diverse opportunities. Penny stocks, often associated with smaller or newer companies, continue to capture interest for their affordability and growth potential despite the term's outdated connotation. This article will explore several Asian penny stocks that stand out due to their financial strength and potential for long-term value.
Top 10 Penny Stocks In Asia
Name | Share Price | Market Cap | Rewards & Risks |
Lever Style (SEHK:1346) | HK$1.40 | HK$883.33M | ✅ 4 ⚠️ 1 View Analysis > |
Ever Sunshine Services Group (SEHK:1995) | HK$2.12 | HK$3.66B | ✅ 4 ⚠️ 2 View Analysis > |
TK Group (Holdings) (SEHK:2283) | HK$2.31 | HK$1.92B | ✅ 3 ⚠️ 1 View Analysis > |
CNMC Goldmine Holdings (Catalist:5TP) | SGD0.45 | SGD182.38M | ✅ 4 ⚠️ 1 View Analysis > |
Goodbaby International Holdings (SEHK:1086) | HK$1.15 | HK$1.92B | ✅ 4 ⚠️ 1 View Analysis > |
T.A.C. Consumer (SET:TACC) | THB4.60 | THB2.76B | ✅ 3 ⚠️ 3 View Analysis > |
China Sunsine Chemical Holdings (SGX:QES) | SGD0.645 | SGD614.93M | ✅ 4 ⚠️ 1 View Analysis > |
Yangzijiang Shipbuilding (Holdings) (SGX:BS6) | SGD2.40 | SGD9.45B | ✅ 5 ⚠️ 0 View Analysis > |
Ekarat Engineering (SET:AKR) | THB0.95 | THB1.4B | ✅ 2 ⚠️ 2 View Analysis > |
Beng Kuang Marine (SGX:BEZ) | SGD0.24 | SGD48.53M | ✅ 4 ⚠️ 3 View Analysis > |
Click here to see the full list of 974 stocks from our Asian Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Huanxi Media Group (SEHK:1003)
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Huanxi Media Group Limited is an investment holding company involved in media and entertainment operations in the People’s Republic of China and Hong Kong, with a market cap of HK$1.65 billion.
Operations: The company generates revenue from its investment in film and TV programmes rights, amounting to HK$34.18 million.
Market Cap: HK$1.65B
Huanxi Media Group, with a market cap of HK$1.65 billion, is currently unprofitable and has less than a year of cash runway based on its free cash flow. Despite generating HK$34.18 million in revenue from film and TV rights, it lacks meaningful revenue streams. The company has reduced losses over the past five years by 4.8% annually and forecasts significant revenue growth at 41.86% per year due to new film releases like "The Stage." Its short-term assets exceed liabilities, but recent insider selling raises caution for investors amid high share price volatility.
- Click here to discover the nuances of Huanxi Media Group with our detailed analytical financial health report.
- Explore Huanxi Media Group's analyst forecasts in our growth report.
Broncus Holding (SEHK:2216)
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: Broncus Holding Corporation is a medical device company that develops interventional pulmonology products for markets in Mainland China, the European Union, and internationally, with a market cap of HK$1.29 billion.
Operations: Broncus Holding's revenue comes from its medical products segment, totaling $8.13 million.
Market Cap: HK$1.29B
Broncus Holding Corporation, with a market cap of HK$1.29 billion, is gaining traction in the medical device sector following recent approvals for its BroncAblate system in China. This innovative lung cancer treatment device marks a significant advancement in minimally invasive therapy. Despite being unprofitable with a negative return on equity of -9.03%, the company has improved its financial position by achieving positive shareholder equity and reducing losses by 27.8% annually over five years. With no long-term liabilities and sufficient cash runway exceeding three years, Broncus is poised for revenue growth projected at 24.72% per year amidst high share price volatility.
- Click here and access our complete financial health analysis report to understand the dynamics of Broncus Holding.
- Gain insights into Broncus Holding's outlook and expected performance with our report on the company's earnings estimates.
Bosideng International Holdings (SEHK:3998)
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Bosideng International Holdings Limited operates in the apparel business in the People's Republic of China with a market capitalization of approximately HK$50.17 billion.
Operations: The company's revenue is primarily generated from Down Apparels at CN¥21.71 billion, followed by Original Equipment Manufacturing (OEM) Management at CN¥3.42 billion, Ladieswear Apparels at CN¥651.15 million, and Diversified Apparels at CN¥231.76 million.
Market Cap: HK$50.17B
Bosideng International Holdings Limited, with a market cap of approximately HK$50.17 billion, has demonstrated stable financial health and growth in the apparel sector. The company reported sales of CN¥25.90 billion for the year ended March 31, 2025, up from CN¥23.21 billion the previous year, alongside net income growth to CN¥3.51 billion from CN¥3.07 billion. Earnings per share have also increased slightly over the past year. Despite significant insider selling recently, Bosideng's debt is well-managed with more cash than total debt and its assets comfortably cover liabilities, indicating robust operational stability in a volatile market segment like penny stocks.
- Dive into the specifics of Bosideng International Holdings here with our thorough balance sheet health report.
- Understand Bosideng International Holdings' earnings outlook by examining our growth report.
Taking Advantage
- Explore the 974 names from our Asian Penny Stocks screener here.
- Want To Explore Some Alternatives? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Bosideng International Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com